Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index Down 0.39% in November; (-1.45% YTD)

Monday, December 17, 2012
Opalesque Industry Update: Managed futures lost 0.39% in November according to the Barclay CTA Index compiled by BarclayHedge. The Index has lost 1.45% year to date, compared to a gain of 0.73% in the S&P GSCI Index.

“Profitable positions in the continuing uptrend in bond markets and the downtrend in the Japanese yen were insufficient to overcome losses in other sectors,” says Sol Waksman, founder and president of BarclayHedge.

Five of Barclay’s eight CTA indices had losses in November. The Agricultural Traders Index dropped 1.23%, Diversified Traders gave up 0.50%, and Systematic Traders lost 0.39%.

“Although the Commodity Research Bureau Index gained 1.10 percent on the month, dispersion across the sector was high as prices for precious and industrial metals rose, energy was mixed, and agricultural markets moved lower,” says Waksman.

The Barclay BTOP50 Index, which measures performance of the largest CTAs, led all managed futures indices in November with a 0.34% gain. Currency Traders were up 0.26%, and Discretionary Traders added 0.04%.

Year to date, the Agricultural Traders Index has gained 6.53%, Discretionary Traders have gained 2.02%, and Currency Traders have a 1.15% return.

Diversified Traders are down 3.36% in 2012, Systematic Traders have lost 3.01%, and the Financial & Metals Traders Index is down 2.54%.

Click here to view 33 years of Barclay CTA Index data.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its